Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

OBJECTIVES: The aim of the study was to evaluate the cost-effectiveness (CE) of treatment with eplerenone versus standard care in adult patients with New York Heart Association class II chronic heart failure and reduced left ventricular ejection fraction from the perspective of the Greek national he...

Descripción completa

Detalles Bibliográficos
Autores principales: Athanasakis, Kostas, Bilitou, Aikaterini, Lee, Dawn, Karampli, Eleftheria, Karavidas, Apostolos, Parissis, John, Sykara, Georgia, Kyriopoulos, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066703/
https://www.ncbi.nlm.nih.gov/pubmed/27785081
http://dx.doi.org/10.2147/CEOR.S107831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066703/
https://www.ncbi.nlm.nih.gov/pubmed/27785081
http://dx.doi.org/10.2147/CEOR.S107831

Ejemplares similares